Discovery of a Novel Antimicrobial Peptide, Temporin-PKE, from the Skin Secretion of Pelophylax kl. esculentus , and Evaluation of Its Structure-Activity Relationships.
Yaxian LinYangyang JiangZiwei ZhaoYueyang LuXinping XiChengbang MaXiaoling ChenMei ZhouTian-Bao ChenChris ShawLei WangPublished in: Biomolecules (2022)
Bacterial resistance against antibiotics has led to increasing numbers of treatment failures, and AMPs are widely accepted as becoming potential alternatives due to their advantages. Temporin-PKE is a novel peptide extracted from the skin secretion of Pelophylax kl. esculentus and it displays a strong activity against Gram-positive bacteria, with an extreme cytotoxicity. Incorporating positively charged residues and introducing D-amino acids were the two main strategies adopted for the modifications. The transformation of the chirality of Ile could reduce haemolytic activity, and an analogue with appropriate D-isoforms could maintain antimicrobial activity and stability. The substitution of hydrophobic residues could bring about more potent and broad-spectrum antimicrobial activities. The analogues with Lys were less harmful to the normal cells and their stabilities remained at similarly high levels compared to temporin-PKE. The optimal number of charges was three, and the replacement on the polar face was a better choice. Temporin-PKE-3K exerted dually efficient functions includingstrong antimicrobial and anticancer activity. This analogue showed a reduced possibility for inducing resistance in MRSA and Klebsiella pneumoniae , a rather strong antimicrobial activity in vivo, and it exhibited the highest therapeutic index such that temporin-PKE-3K has the potential to be developed as a clinical drug.
Keyphrases
- klebsiella pneumoniae
- staphylococcus aureus
- multidrug resistant
- escherichia coli
- induced apoptosis
- amino acid
- small molecule
- gram negative
- soft tissue
- human health
- ionic liquid
- cell cycle arrest
- climate change
- high throughput
- risk assessment
- molecular docking
- signaling pathway
- endoplasmic reticulum stress
- decision making
- adverse drug